Published in Heart Asia on November 19, 2013
Long-term (52-week) safety and efficacy of Sacubitril/valsartan in Asian patients with hypertension. Hypertens Res (2016) 0.79
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA (2003) 97.28
Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet (2004) 39.54
Global burden of hypertension: analysis of worldwide data. Lancet (2005) 32.76
Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract (2009) 25.83
Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care (1993) 17.66
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet (2010) 14.40
Obesity and the metabolic syndrome in children and adolescents. N Engl J Med (2004) 13.99
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2013) 12.73
Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA (2002) 6.84
Worldwide prevalence of hypertension: a systematic review. J Hypertens (2004) 6.25
Diabetes in Asia. Lancet (2009) 5.96
Management of hypertension: summary of NICE guidance. BMJ (2011) 5.60
Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association. Hypertension (2006) 5.59
Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet (2001) 5.54
Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation (2008) 5.26
Retracted Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study. Lancet (2007) 5.17
Prevalence of hypertension and pre-hypertension among adolescents. J Pediatr (2007) 4.63
Prevalence, awareness, treatment, and control of hypertension in China: data from the China National Nutrition and Health Survey 2002. Circulation (2008) 4.29
Prevalence, awareness, treatment, and control of hypertension in china. Hypertension (2002) 4.18
Trends in blood pressure among children and adolescents. JAMA (2004) 4.03
[Predictive values of body mass index and waist circumference to risk factors of related diseases in Chinese adult population]. Zhonghua Liu Xing Bing Xue Za Zhi (2002) 3.43
Blood pressure and the global burden of disease 2000. Part II: estimates of attributable burden. J Hypertens (2006) 3.12
Prevalence, awareness, treatment and control of hypertension among the elderly in Bangladesh and India: a multicentre study. Bull World Health Organ (2001) 2.99
Incidence and prognosis of resistant hypertension in hypertensive patients. Circulation (2012) 2.99
Epidemiology of uncontrolled hypertension in the United States. Circulation (2005) 2.79
Cardiovascular disease in the developing world and its cost-effective management. Circulation (2005) 2.57
Ethnic comparisons of the cross-sectional relationships between measures of body size with diabetes and hypertension. Obes Rev (2008) 2.32
Weight loss intervention in phase 1 of the Trials of Hypertension Prevention. The TOHP Collaborative Research Group. Arch Intern Med (1993) 2.26
Cardiovascular disease in developing countries: myths, realities, and opportunities. Cardiovasc Drugs Ther (1999) 2.05
Hypertension in children and adolescents: epidemiology and natural history. Pediatr Nephrol (2009) 1.84
Novel baroreflex activation therapy in resistant hypertension: results of a European multi-center feasibility study. J Am Coll Cardiol (2010) 1.82
Hypertension and stroke in Asia: prevalence, control and strategies in developing countries for prevention. J Hum Hypertens (2001) 1.72
Relationship of blood pressure control and hospitalization risk to medication adherence among patients with hypertension in Taiwan. Am J Hypertens (2009) 1.71
The relationship between hypertension and obesity across different ethnicities. J Hypertens (2012) 1.60
Prevalence of insulin resistance and related risk factors for cardiovascular disease in patients with essential hypertension. Am J Hypertens (2008) 1.60
Hypertension prevalence, awareness, treatment, control, and associated factors in adults in southern China. Am J Hypertens (2012) 1.53
Trends and social factors in blood pressure control in Scottish MONICA surveys 1986-1995: the rule of halves revisited. J Hum Hypertens (2003) 1.30
Prevalence, awareness, treatment and control of hypertension and diabetes mellitus among the elderly: the 2004 National Health Examination Survey III, Thailand. Singapore Med J (2008) 1.29
Resistant hypertension--its identification and epidemiology. Nat Rev Nephrol (2012) 1.26
Comparison of enalapril and nifedipine in treating non-insulin dependent diabetes associated with hypertension: one year analysis. BMJ (1992) 1.15
Prevalence, awareness, treatment, control and risk factors for hypertension in a rural population in South India. Int J Public Health (2011) 1.13
Risk factors associated with hypertension awareness, treatment, and control in a multi-ethnic Asian population. J Hypertens (2009) 1.09
ACE inhibitors, beta-blockers, calcium blockers, and diuretics for the control of systolic hypertension. Am J Hypertens (2001) 1.04
The optimal target blood pressure for antihypertensive treatment in Japanese elderly patients with high-risk hypertension: a subanalysis of the Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) trial. Hypertens Res (2008) 1.03
Factors associated with prevalence, awareness, treatment and control of hypertension in urban adults from 33 communities in China: the CHPSNE Study. Hypertens Res (2011) 1.03
Prevalence, awareness, treatment and control of hypertension in the elderly population of Singapore. Hypertens Res (2010) 0.99
Current status and characteristics of hypertension control in community resident elderly Korean people: data from a Korean longitudinal study on health and aging (KLoSHa study). Hypertens Res (2008) 0.99
Obesity-hypertension: an ongoing pandemic. Int J Clin Pract (2007) 0.95
Prevalence, awareness, treatment, and control of hypertension among people over 40 years old in a rural area of South Korea: The Chungju Metabolic Disease Cohort (CMC) Study. Clin Exp Hypertens (2010) 0.94
Current status and characteristics of hypertension treatment by primary physicians in Korea: data from Korean epidemiology study on hypertension (KEY study). Am J Hypertens (2008) 0.93
Hypertension in elderly persons: its prevalence and associated cardiovascular risk factors in Tainan City, southern Taiwan. J Gerontol A Biol Sci Med Sci (2000) 0.89
Association between raised blood pressure and dysglycemia in Hong Kong Chinese. Diabetes Care (2008) 0.86
Blood pressure control in a Japanese population with chronic kidney disease: a baseline survey of a nationwide cohort. Am J Hypertens (2011) 0.84
Short-term adherence to beta-blocker therapy among ethnic Chinese patients with hypertension: a cohort study. Clin Ther (2009) 0.83
Factors associated with compliance, discontinuation and switching of calcium channel blockers in 20,156 Chinese patients. Am J Hypertens (2009) 0.83
Patterns of antihypertensive prescribing, discontinuation and switching among a Hong Kong Chinese population from over one million prescriptions. J Hum Hypertens (2008) 0.83
Sex differences in blood pressure response to antihypertensive therapy in Chinese patients with hypertension. Ann Pharmacother (2008) 0.83
Antihypertensive drug adherence among 6408 Chinese patients on angiotensin-converting enzyme inhibitors in Hong Kong: a cohort study. J Clin Pharmacol (2009) 0.81
Management of hypertension: evidence from the Blood Pressure Lowering Treatment Trialists' Collaboration and from major clinical trials. Pol Arch Med Wewn (2009) 0.80
Profiles of mortality among Chinese hypertensive patients in Hong Kong: a cohort study. J Hum Hypertens (2009) 0.79
Hypertension management in diabetic patients: prescribing trends from 1999 to 2005 in three Japanese university hospitals. Pharmacoepidemiol Drug Saf (2008) 0.79
Prescribing pattern of antihypertensive drugs in a general hospital in central China. Int J Clin Pharm (2011) 0.76